Primary RET-mutated lung neuroendocrine carcinoma in MEN2B: response to RET-targeted therapy

Jessica L Geiger1, Simion I Chiosea1, Sue M Challinor1

  • 1Division of Hematology/Oncology, Department of Internal Medicine, University of Pittsburgh Cancer Institute5150 Centre Avenue, 5th Floor, Pittsburgh, Pennsylvania, 15232USADivision of Anatomic Pathology, Department of Pathology, University of Pittsburgh Medical CenterPittsburgh, PennsylvaniaUSADivision of Endocrinology and Metabolism, Department of Internal Medicine, University of Pittsburgh Medical CenterPittsburgh, PennsylvaniaUSADivision of Molecular Genomic Pathology, Department of Pathology, University of Pittsburgh Medical CenterPittsburgh, PennsylvaniaUSA.

Endocrine-Related Cancer
|August 20, 2015
PubMed
Abstract

No abstract available in PubMed .